Skip to Content

G 371 (Topiramate Extended-Release 200 mg)

Pill with imprint G 371 is Brown / Gray, Capsule-shape and has been identified as Topiramate Extended-Release 200 mg. It is supplied by Glenmark Pharmaceuticals Inc..

Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; migraine prevention; seizure prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for G 371

Topiramate Extended-Release

Imprint
G 371
Strength
200 mg
Color
Brown / Gray
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Glenmark Pharmaceuticals Inc.
National Drug Code (NDC)
68462-0371

Get help with Imprint Code FAQs.

Related Images for "G 371"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.